Equity Capital Markets

Company · CIK 1672619

Enliven Therapeutics, Inc.

CIK1672619 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedELVN (Nasdaq)
First annual or quarterly report2020-05-07

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-289582
ShelfEffective
 2025-08-132026-06-123
333-272909
ShelfEffective
 2023-06-232025-06-165
333-278801
ShelfEffective
 2024-04-182024-04-302
333-254978
ShelfEffective
 2021-04-012022-03-155
333-236465
IPOFinal prospectus
 2020-02-142020-03-125

Filings

22
FiledFilingRegistrationAccession
2026-06-12424B5Shelf takedown 333-2895820001193125-26-269621
2026-06-11424B5Shelf takedown 333-2895820001193125-26-267938
2025-08-13S-3ASRShelf registered 333-2895820001193125-25-179946
2025-06-16424B5Shelf takedown 333-2729090001193125-25-140928
2025-06-13424B5Shelf takedown 333-2729090001193125-25-140298
2024-04-30EFFECTDeclared effective 333-2788019999999995-24-001220
2024-04-18S-3Shelf registered 333-2788010001193125-24-100863
2023-07-06424B5Shelf takedown 333-2729090001193125-23-182776
2023-07-03EFFECTDeclared effective 333-2729099999999995-23-001974
2023-06-23S-3Shelf registered 333-2729090001193125-23-173982
2023-01-23EFFECTDeclared effective 333-2683009999999995-23-000162
2022-03-15424B5Shelf takedown 333-2549780001193125-22-076183
2021-07-14424B5Shelf takedown 333-2549780001193125-21-215250
2021-07-13424B5Shelf takedown 333-2549780001193125-21-214130
2021-04-08EFFECTDeclared effective 333-2549789999999995-21-001366
2021-04-01S-3Shelf registered 333-2549780001193125-21-104174
2020-03-12424B4Final prospectus 333-2364650001193125-20-071536
2020-03-11EFFECTDeclared effective 333-2364659999999995-20-000554
2020-03-10S-1/AAmendment 333-2364650001193125-20-068143
2020-03-03S-1/AAmendment 333-2364650001193125-20-059618
2020-02-14S-1Registration filed 333-2364650001193125-20-038557
2019-08-15DRSDraft made public 377-027950000950123-19-008513

All filings of this company · CSV